National Eye Institute
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1968-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.nei.nih.gov
Training to Modify Fixational Eye Movements for Optimizing Visual Performance in People With Central Vision Loss
- Conditions
- Central Vision Loss From Macular Diseases
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 30
- Registration Number
- NCT06670989
- Locations
- 🇺🇸
Herbert Wertheim School of Optometry & Vision Science, University of California Berkeley, Berkeley, California, United States
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
- Conditions
- Hypopigmentation DisorderAniridiaInherited Ophthalmic DiseasesBlue-cone MonochromacyAlbinismCorneal DystrophyBest Disease
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 1000
- Registration Number
- NCT06491615
- Locations
- 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States
🇺🇸National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Potential Environmental Causes of Uveal Coloboma
- Conditions
- Coloboma
- First Posted Date
- 2021-04-06
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 76
- Registration Number
- NCT04833361
- Locations
- 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States
Microbiome as a ThErapeutic Response Biomarker
- Conditions
- Uveitis
- First Posted Date
- 2021-01-25
- Last Posted Date
- 2021-05-06
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT04721743
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Biomarkers in Ocular Inflammation and Uveitis
- Conditions
- UveitisOcular Inflammation
- First Posted Date
- 2020-12-31
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 69
- Registration Number
- NCT04690829
- Locations
- 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States
Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors
- Conditions
- COVID-19
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 8
- Registration Number
- NCT04665752
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4
- Conditions
- Stargardt-Like Macular Dystrophy
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 25
- Registration Number
- NCT04591483
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Oral Metformin for Treatment of ABCA4 Retinopathy
- Conditions
- Stargardt DiseaseABCA4 RetinopathyRetinal DystrophyRetinal Degeneration
- Interventions
- First Posted Date
- 2020-09-11
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 56
- Registration Number
- NCT04545736
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma
- Conditions
- Retinal HemangioblastomaVon Hippel-Lindau Disease
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 25
- Registration Number
- NCT04458935
- Locations
- 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
- Conditions
- Dry Age-Related Macular DegenerationGeographic Atrophy
- Interventions
- Drug: iPSC-derived RPE/PLGA transplantation
- First Posted Date
- 2020-04-09
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- National Eye Institute (NEI)
- Target Recruit Count
- 20
- Registration Number
- NCT04339764
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸National Institutes of Health Clinical Center, Bethesda, Maryland, United States